OmniAb Inc reports results for the quarter ended in December - Earnings Summary

OmniAB

20/03/2024 21:01

* OmniAb Inc  OABI.OQ  reported a quarterly adjusted loss
of 14
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of 7
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 15 cents per share. Wall Street expected
results to range from -20 cents to -11 cents per share.
    * Revenue fell 86.4% to $4.82 million from a year ago;
analysts
expected $7.47 million. 
    * OmniAb Inc's reported EPS for the quarter was a loss of 14
cents​.
    * The company reported a quarterly loss of $14.05 million.
    * OmniAb Inc shares had fallen by 14.6% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for OmniAb Inc is
$10.00 
This summary was machine generated from LSEG data March 20 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.15          -0.14          Beat
 Sep. 30 2023      -0.14          -0.16          Missed
 Jun. 30 2023      -0.12          -0.15          Missed
 Mar. 31 2023      -0.03          -0.08          Missed